Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

• Päätekijät: Qi-An Chen (Tekijä), Wei-Hao Lin (Tekijä), Xiao-Xiang Zhou (Tekijä), Zheng Cao (Tekijä), Xiao-Li Feng (Tekijä), Yi-Bo Gao (Tekijä), Jie He (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2024-02-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...